Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Diffusion Pharmaceuticals Inc. (DFFN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
6.77+0.19 (+2.89%)
At close: 04:00PM EDT
6.50 -0.27 (-3.99%)
After hours: 05:06PM EDT
Advertisement

Diffusion Pharmaceuticals Inc.

300 East Main Street
Suite 201
Charlottesville, VA 22902
United States
434 220 0718
https://www.diffusionpharma.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees16

Key Executives

NameTitlePayExercisedYear Born
Dr. Robert J. Cobuzzi Jr.Pres, CEO & Director1.23MN/A1965
Mr. William Karl HornungChief Financial Officer450.68kN/A1969
Mr. William Robert Elder J.D.Gen. Counsel & Corp. Sec.338.36kN/A1983
Dr. Christopher D. Galloway M.D.Chief Medical Officer539.59kN/A1971
Dr. David Randolph Jones M.D.Sr. Medical AdvisorN/AN/A1963
Ms. Suzanne CassidySr. Director & Head of Quality AssuranceN/AN/AN/A
Dr. Jennifer Llewelyn Ph.D.Sr. Director & Head of CMCN/AN/AN/A
Ms. Kelly HoyDirector of Project ManagementN/AN/AN/A
Mr. Harry CookVP of Clinical OperationsN/AN/AN/A
Mr. Douglas GravattSr. Consultant for ManufacturingN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia.

Corporate Governance

Diffusion Pharmaceuticals Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement